Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,138 Jul 29 – Oct 26, 2026
- Disclosed funding
- $145B 1462 disclosed amounts
- Median round
- $10M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
HiasynthCompany profile Hiasynth sells Humanity, a synthetic population model that market researchers and commercial teams can query through AI tools to estimate audience sizes, compare locations and understand consumer segments across Europe. Its MCP server returns calibrated aggregate statistics rather than data about real individuals. Hiasynth sells Humanity, a synthetic population model that market researchers and commercial teams can query through AI tools to estimate audience sizes, compare locations and understand consumer segments across Europe. Its MCP server returns calibrated aggregate statistics rather than data about real individuals. | Undisclosed | Angel fundingUndisclosed | AI | Sweden | Investors | |
Konko AICompany profile Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. Konko AI builds Kora, a patient-communications assistant for clinics and hospitals. | $6M | FundingUndisclosed | Healthtech | United States | Investors | |
N-Power MedicineCompany profile N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers. | $32M | Series B | Healthtech | United States | Investors | |
| Kn Kimi no Tonari, Inc.Company profile The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings. The developer of Uratchi, an AI fortune-telling app offering personalized relationship guidance and chat readings. | Undisclosed | Series A | AI | Japan | Investors | |
Oppex AICompany profile Oppex AI builds an AI-native incident-management platform for engineering and SRE teams. Oppex AI builds an AI-native incident-management platform for engineering and SRE teams. | ₹42M | Pre-seed | Developer tools | India | Investors | |
ArchiveCompany profile A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. A creator-marketing and social-listening platform that finds brand-related short-form video, manages creator campaigns and helps teams reuse user-generated content. | Undisclosed | Growth investmentGrowth | Media & gaming | United States | Investors | |
BullCompany profile White-label credit infrastructure and operating services that help businesses launch and manage payroll-backed worker loans in Brazil. White-label credit infrastructure and operating services that help businesses launch and manage payroll-backed worker loans in Brazil. | $3.7M | Seed | Fintech | Brazil | Investors | |
Nexedge CapitalCompany profile Nexedge Capital combines wealth-management technology with multi-family-office services for ultra-high-net-worth individuals, families, entrepreneurs, and institutions. Nexedge Capital combines wealth-management technology with multi-family-office services for ultra-high-net-worth individuals, families, entrepreneurs, and institutions. | $20M | First funding roundUndisclosed | Fintech | India | Investors | |
NewlightCompany profile Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. Newlight develops a hydrogen-hybrid retrofit for commercial ships that injects hydrogen into existing diesel engines to improve combustion, reducing fuel use and emissions without replacing the engine. | $9M | Seed | Climate tech | United States | Investors | |
| TT Typewriter TherapeuticsCompany profile Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. Typewriter Therapeutics is developing an all-RNA gene-writing platform that inserts therapeutic genes at a defined genomic site without viral vectors or double-strand DNA breaks. Its programs target in vivo engineered CAR-T cells and gene insertion for severe genetic diseases, including liver disorders. | $56M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 29, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
71rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
46rounds18led - 3Khosla Ventures
Arda Industries, Tolan
33rounds10led - 4Sequoia Capital
Nevis, Warhound, Whop
32rounds11led - 5General Catalyst
Matiks, Provision Labs, Tractian
31rounds12led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →